Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Sinonasal inhalation of dornase alfa in CF: A double-blind placebo-controlled cross-over pilot trial.

Mainz JG, Schiller I, Ritschel C, Mentzel HJ, Riethmüller J, Koitschev A, Schneider G, Beck JF, Wiedemann B.

Auris Nasus Larynx. 2011 Apr;38(2):220-7. doi: 10.1016/j.anl.2010.09.001. Epub 2010 Oct 27.

PMID:
21030168
2.

Sinonasal inhalation of dornase alfa administered by vibrating aerosol to cystic fibrosis patients: a double-blind placebo-controlled cross-over trial.

Mainz JG, Schien C, Schiller I, Schädlich K, Koitschev A, Koitschev C, Riethmüller J, Graepler-Mainka U, Wiedemann B, Beck JF.

J Cyst Fibros. 2014 Jul;13(4):461-70. doi: 10.1016/j.jcf.2014.02.005. Epub 2014 Mar 1.

3.

Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.

Cimmino M, Nardone M, Cavaliere M, Plantulli A, Sepe A, Esposito V, Mazzarella G, Raia V.

Arch Otolaryngol Head Neck Surg. 2005 Dec;131(12):1097-101.

PMID:
16365224
4.

Nasally inhaled dornase alfa in the postoperative management of chronic sinusitis due to cystic fibrosis.

Raynor EM, Butler A, Guill M, Bent JP 3rd.

Arch Otolaryngol Head Neck Surg. 2000 May;126(5):581-3.

PMID:
10807324
5.
6.

Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial.

Bakker EM, Volpi S, Salonini E, Müllinger B, Kroneberg P, Bakker M, Hop WC, Assael BM, Tiddens HA.

Pediatr Pulmonol. 2014 Feb;49(2):154-61. doi: 10.1002/ppul.22800. Epub 2013 Jul 3.

PMID:
23913868
7.

Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis - Results of a multicenter, prospective, randomized, double-blind, controlled trial.

Mainz JG, Schumacher U, Schädlich K, Hentschel J, Koitschev C, Koitschev A, Riethmüller J, Prenzel F, Sommerburg O, Wiedemann B, Staab D, Gleiber W, Fischer R, Beck JF, Arnold C; Cooperators.

J Cyst Fibros. 2016 Nov;15(6):e57-e66. doi: 10.1016/j.jcf.2016.05.003. Epub 2016 Jun 5.

PMID:
27267518
8.

A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.

Fitzgerald DA, Hilton J, Jepson B, Smith L.

Pediatrics. 2005 Oct;116(4):e549-54. Epub 2005 Sep 1.

PMID:
16147970
9.

Management of chronic rhinosinusitis in CF.

Mainz JG, Koitschev A.

J Cyst Fibros. 2009 Jun;8 Suppl 1:S10-4. doi: 10.1016/S1569-1993(09)60005-9.

10.

Medical management of chronic rhinosinusitis in cystic fibrosis: a systematic review.

Liang J, Higgins T, Ishman SL, Boss EF, Benke JR, Lin SY.

Laryngoscope. 2014 Jun;124(6):1308-13. doi: 10.1002/lary.24503. Epub 2013 Dec 11. Review.

PMID:
24338982
11.

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.

Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW; Pulmozyme Early Intervention Trial Study Group.

J Pediatr. 2001 Dec;139(6):813-20.

PMID:
11743506
12.

Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study.

Mainz JG, Schädlich K, Schien C, Michl R, Schelhorn-Neise P, Koitschev A, Koitschev C, Keller PM, Riethmüller J, Wiedemann B, Beck JF.

Drug Des Devel Ther. 2014 Feb 10;8:209-17. doi: 10.2147/DDDT.S54064. eCollection 2014.

13.

[An update on cystic fibrosis for the ENT-specialist].

Rozsasi A, Keck T.

Laryngorhinootologie. 2003 Oct;82(10):715-25; quiz 726-30. German.

PMID:
14593571
14.

Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group.

Geller DE, Eigen H, Fiel SB, Clark A, Lamarre AP, Johnson CA, Konstan MW.

Pediatr Pulmonol. 1998 Feb;25(2):83-7.

PMID:
9516090
15.

Does the timing of inhaled dornase alfa matter?

van der Giessen L.

J Cyst Fibros. 2009 Jun;8 Suppl 1:S6-9. doi: 10.1016/S1569-1993(09)60004-7.

17.

Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation.

Bakker EM, Volpi S, Salonini E, van der Wiel-Kooij EC, Sintnicolaas CJ, Hop WC, Assael BM, Merkus PJ, Tiddens HA.

Eur Respir J. 2011 Dec;38(6):1328-35. doi: 10.1183/09031936.00006211. Epub 2011 Jul 7.

18.

Randomized trial of efficacy and safety of dornase alfa delivered by eRapid nebulizer in cystic fibrosis patients.

Sawicki GS, Chou W, Raimundo K, Trzaskoma B, Konstan MW.

J Cyst Fibros. 2015 Nov;14(6):777-83. doi: 10.1016/j.jcf.2015.04.003. Epub 2015 Apr 25.

19.

Dornase alpha and exhaled NO in cystic fibrosis.

Grasemann H, Lax H, Treseler JW, Colin AA.

Pediatr Pulmonol. 2004 Nov;38(5):379-85.

PMID:
15390350
20.

[Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa].

Derelle J, Bertolo-Houriez E, Marchal F, Weber M, Virion JM, Vidailhet M.

Arch Pediatr. 1998 Apr;5(4):371-7. French.

PMID:
9759155

Supplemental Content

Support Center